Clinical Trials Directory

Trials / Conditions / Apatinib

Apatinib

18 registered clinical trials studyying Apatinib — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therap
NCT07031154
The First Affiliated Hospital of Xiamen UniversityPhase 2
RecruitingTACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma
NCT06485466
Guohui XuPhase 3
CompletedDEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic Cholangiocarcinoma
NCT04834674
Sichuan Cancer Hospital and Research InstitutePhase 2
RecruitingCamrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma
NCT05512481
Peking University Cancer Hospital & InstitutePhase 2
UnknownNeoadjuvant Carilizumab and Apatinib for Recurrent High-Grade Glioma
NCT04588987
Sun Yat-sen UniversityPhase 2
WithdrawnApatinib for Resectable Colorectal Cancer
NCT03228043
Nanchong Central HospitalN/A
CompletedFirst-line Chemotherapy for Recurrent Cervical Cancer
NCT04188847
Lei LiPhase 2
UnknownPulmonary Resectable Metastases of Osteosarcoma With Anti-angiogenics and CHemotherapy
NCT03742193
Ruijin HospitalPhase 2
UnknownApatinib Plus SHR1210 in Advanced Mucosal Melanoma
NCT03986515
Henan Cancer HospitalPhase 2
UnknownStudy of Neoadjuvant Regimen for Radioactive Iodine Treatment of Metastatic and Advanced Differentiated Thyroi
NCT04180007
Nanjing First Hospital, Nanjing Medical UniversityPhase 2
UnknownApatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer
NCT03913182
Shanghai Chest HospitalPhase 2
UnknownThe Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer
NCT03889626
Fudan UniversityPhase 3
CompletedmFOLFOX6 Chemotherapy With Apatinib as Postoperative Treatment in Stage IIIB or IIIC Colorectal Cancer
NCT03365765
Huashan HospitalPhase 3
UnknownApatinib Combined With EGFR-TKI for Advanced Slow-progressed EGFR-TKI Resistant NSCLC
NCT03428022
Shenzhen People's HospitalPhase 3
UnknownApatinib as the First-Line Therapy in Elderly Locally Advanced or Metastatic Gastric Cancer
NCT03219593
The First Affiliated Hospital of Bengbu Medical UniversityPhase 2
UnknownApatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC
NCT03201146
West China HospitalPhase 1 / Phase 2
UnknownA Clinical Trial With Apatinib for Subjects With Refractory Malignant Ascites
NCT03020979
The First Affiliated Hospital of Bengbu Medical UniversityPhase 2
UnknownApatinib for Metastatic Esophageal Cancer.
NCT02544737
Hangzhou Cancer HospitalPhase 2